{
    "Trade/Device Name(s)": [
        "Fungitell STAT"
    ],
    "Submitter Information": "Associates of Cape Cod, Inc.",
    "510(k) Number": "K191167",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN040003"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQZ"
    ],
    "Summary Letter Date": "July 17, 2019",
    "Summary Letter Received Date": "May 1, 2019",
    "Submission Date": "April 9, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3050"
    ],
    "Regulation Name(s)": [
        "Beta-Glucan Serological Assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "(1\u21923)-\u03b2-D-glucan"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Spectrophotometric tube reader capable of kinetic reading at 405 nm and minus the background at 495 nm"
    ],
    "Method(s)/Technology(ies)": [
        "Protease zymogen-based colorimetric assay"
    ],
    "Methodologies": [
        "Colorimetric detection",
        "Limulus Amebocyte Lysate pathway"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Standard"
    ],
    "Document Summary": "FDA 510(k) summary for Fungitell STAT colorimetric assay for qualitative detection of (1\u21923)-\u03b2-D-glucan in serum as an aid in diagnosing invasive fungal infection.",
    "Indications for Use Summary": "Qualitative detection of (1\u21923)-\u03b2-D-glucan in the serum of patients with symptoms of or risk factors for invasive fungal infection, as an aid in diagnosis of deep-seated mycoses and fungemias, used with other diagnostic procedures.",
    "fda_folder": "Microbiology"
}